Cargando…
Lyoprotectant Formulation and Optimization of the J-Aggregates Astaxanthin/BSA/Chitosan Nanosuspension
Astaxanthin is a carotenoid with excellent antioxidant activity. However, this small lipid-soluble molecule is insoluble in water and has low stability. Although this situation can be improved when astaxanthin is prepared as a nanosuspension, the aqueous form is still not as convenient and safe as t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046545/ https://www.ncbi.nlm.nih.gov/pubmed/36979431 http://dx.doi.org/10.3390/biom13030496 |
_version_ | 1785013699687219200 |
---|---|
author | Zhao, Yingyuan Wang, Zhaoxuan Liu, Shuxian Xie, Shiying Xie, Yinchun Li, Ruifang Oda, Hiroaki |
author_facet | Zhao, Yingyuan Wang, Zhaoxuan Liu, Shuxian Xie, Shiying Xie, Yinchun Li, Ruifang Oda, Hiroaki |
author_sort | Zhao, Yingyuan |
collection | PubMed |
description | Astaxanthin is a carotenoid with excellent antioxidant activity. However, this small lipid-soluble molecule is insoluble in water and has low stability. Although this situation can be improved when astaxanthin is prepared as a nanosuspension, the aqueous form is still not as convenient and safe as the dry powder form for storage, transport, and use. The lyophilization process provides better protection for thermosensitive materials, but this leads to collapse and agglomeration between nanoparticles. To improve this situation, appropriate lyophilization protectants are needed to offer support between the nanoparticles, such as sugars, amino acids, and hydroxy alcohols. The purpose of this work is to screen lyophilization protectants by single-factor experiments and response surface optimization experiments and then explore the optimal ratio of compound lyophilization protectants, and finally, make excellent astaxanthin/BSA/chitosan nanosuspension (ABC-NPs) lyophilized powder. The work shows that the optimal ratio of the compounding lyophilization protectant is 0.46% oligomeric mannose, 0.44% maltose, and 0.05% sorbitol (w/v). The ABC-NPs lyophilized powder prepared under the above conditions had a re-soluble particle size of 472 nm, with a ratio of 1.32 to the particle size of the sample before lyophilization. The lyophilized powder was all in the form of a pink layer. The sample was fluffy and dissolved entirely within 10 s by shaking with water. Consequently, it is expected to solve the problem of inconvenient storage and transportation of aqueous drugs and to expand the application of nanomedicine powders and tablets. |
format | Online Article Text |
id | pubmed-10046545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100465452023-03-29 Lyoprotectant Formulation and Optimization of the J-Aggregates Astaxanthin/BSA/Chitosan Nanosuspension Zhao, Yingyuan Wang, Zhaoxuan Liu, Shuxian Xie, Shiying Xie, Yinchun Li, Ruifang Oda, Hiroaki Biomolecules Article Astaxanthin is a carotenoid with excellent antioxidant activity. However, this small lipid-soluble molecule is insoluble in water and has low stability. Although this situation can be improved when astaxanthin is prepared as a nanosuspension, the aqueous form is still not as convenient and safe as the dry powder form for storage, transport, and use. The lyophilization process provides better protection for thermosensitive materials, but this leads to collapse and agglomeration between nanoparticles. To improve this situation, appropriate lyophilization protectants are needed to offer support between the nanoparticles, such as sugars, amino acids, and hydroxy alcohols. The purpose of this work is to screen lyophilization protectants by single-factor experiments and response surface optimization experiments and then explore the optimal ratio of compound lyophilization protectants, and finally, make excellent astaxanthin/BSA/chitosan nanosuspension (ABC-NPs) lyophilized powder. The work shows that the optimal ratio of the compounding lyophilization protectant is 0.46% oligomeric mannose, 0.44% maltose, and 0.05% sorbitol (w/v). The ABC-NPs lyophilized powder prepared under the above conditions had a re-soluble particle size of 472 nm, with a ratio of 1.32 to the particle size of the sample before lyophilization. The lyophilized powder was all in the form of a pink layer. The sample was fluffy and dissolved entirely within 10 s by shaking with water. Consequently, it is expected to solve the problem of inconvenient storage and transportation of aqueous drugs and to expand the application of nanomedicine powders and tablets. MDPI 2023-03-08 /pmc/articles/PMC10046545/ /pubmed/36979431 http://dx.doi.org/10.3390/biom13030496 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhao, Yingyuan Wang, Zhaoxuan Liu, Shuxian Xie, Shiying Xie, Yinchun Li, Ruifang Oda, Hiroaki Lyoprotectant Formulation and Optimization of the J-Aggregates Astaxanthin/BSA/Chitosan Nanosuspension |
title | Lyoprotectant Formulation and Optimization of the J-Aggregates Astaxanthin/BSA/Chitosan Nanosuspension |
title_full | Lyoprotectant Formulation and Optimization of the J-Aggregates Astaxanthin/BSA/Chitosan Nanosuspension |
title_fullStr | Lyoprotectant Formulation and Optimization of the J-Aggregates Astaxanthin/BSA/Chitosan Nanosuspension |
title_full_unstemmed | Lyoprotectant Formulation and Optimization of the J-Aggregates Astaxanthin/BSA/Chitosan Nanosuspension |
title_short | Lyoprotectant Formulation and Optimization of the J-Aggregates Astaxanthin/BSA/Chitosan Nanosuspension |
title_sort | lyoprotectant formulation and optimization of the j-aggregates astaxanthin/bsa/chitosan nanosuspension |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046545/ https://www.ncbi.nlm.nih.gov/pubmed/36979431 http://dx.doi.org/10.3390/biom13030496 |
work_keys_str_mv | AT zhaoyingyuan lyoprotectantformulationandoptimizationofthejaggregatesastaxanthinbsachitosannanosuspension AT wangzhaoxuan lyoprotectantformulationandoptimizationofthejaggregatesastaxanthinbsachitosannanosuspension AT liushuxian lyoprotectantformulationandoptimizationofthejaggregatesastaxanthinbsachitosannanosuspension AT xieshiying lyoprotectantformulationandoptimizationofthejaggregatesastaxanthinbsachitosannanosuspension AT xieyinchun lyoprotectantformulationandoptimizationofthejaggregatesastaxanthinbsachitosannanosuspension AT liruifang lyoprotectantformulationandoptimizationofthejaggregatesastaxanthinbsachitosannanosuspension AT odahiroaki lyoprotectantformulationandoptimizationofthejaggregatesastaxanthinbsachitosannanosuspension |